Bausch Financial Statements From 2010 to 2024
BLCO Stock | USD 19.81 0.43 2.22% |
Gross Profit 2.2 B | Profit Margin (0.08) | Market Capitalization 7 B | Enterprise Value Revenue 2.4073 | Revenue 4.7 B |
Bausch Lomb Total Revenue |
|
Check Bausch Lomb financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bausch Lomb's main balance sheet or income statement drivers, such as Tax Provision of 67.1 M, Interest Income of 15.8 M or Depreciation And Amortization of 344.3 M, as well as many indicators such as Price To Sales Ratio of 1.94, Dividend Yield of 0.0 or PTB Ratio of 0.61. Bausch financial statements analysis is a perfect complement when working with Bausch Lomb Valuation or Volatility modules.
Bausch | Select Account or Indicator |
Bausch Lomb Balance Sheet | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bausch Lomb Income Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bausch Lomb Cash Flow Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Ratios | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Bausch Fundamental Market Drivers
Forward Price Earnings | 17.094 | |
Cash And Short Term Investments | 331 M |
Bausch Upcoming Events
28th of February 2024 Upcoming Quarterly Report | View | |
1st of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
28th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
About Bausch Lomb Financial Statements
Bausch Lomb investors utilize fundamental indicators, such as revenue or net income, to predict how Bausch Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last Reported | Projected for Next Year | ||
Current Deferred Revenue | 721 M | 757.1 M | |
Total Revenue | 4.1 B | 4.1 B | |
Cost Of Revenue | 1.6 B | 1.6 B | |
Stock Based Compensation To Revenue | 0.02 | 0.01 | |
Sales General And Administrative To Revenue | 0.33 | 0.23 | |
Research And Ddevelopement To Revenue | 0.08 | 0.06 | |
Capex To Revenue | 0.04 | 0.04 | |
Revenue Per Share | 11.83 | 8.58 | |
Ebit Per Revenue | 0.03 | 0.03 |
Pair Trading with Bausch Lomb
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bausch Lomb position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Lomb will appreciate offsetting losses from the drop in the long position's value.Moving against Bausch Stock
0.86 | FORA | Forian Inc | PairCorr |
0.74 | IVP | Inspire Veterinary | PairCorr |
0.62 | AMN | AMN Healthcare Services | PairCorr |
0.59 | AGL | agilon health | PairCorr |
0.55 | EVH | Evolent Health | PairCorr |
The ability to find closely correlated positions to Bausch Lomb could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bausch Lomb when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bausch Lomb - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bausch Lomb Corp to buy it.
The correlation of Bausch Lomb is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bausch Lomb moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bausch Lomb Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bausch Lomb can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Bausch Lomb Correlation against competitors. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Lomb. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Lomb listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.89) | Earnings Share (1.04) | Revenue Per Share 13.327 | Quarterly Revenue Growth 0.188 | Return On Assets 0.0089 |
The market value of Bausch Lomb Corp is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Lomb's value that differs from its market value or its book value, called intrinsic value, which is Bausch Lomb's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Lomb's market value can be influenced by many factors that don't directly affect Bausch Lomb's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Lomb's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Lomb is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Lomb's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.